Thomas R Staab II insider trades

Open-market stock purchases and sales by Thomas R Staab II, Chief Financial Officer at Tenax Therapeutics, Inc, from SEC Form 4 filings since Mar 18, 2010.

Track record: 67% of 3 scored buys are up 5% or more since purchase, averaging +57%.

Recent trades

DateStockTradeValue
Sep 11, 2026TENX Tenax Therapeutics, IncBought$11K
May 11, 2026TENX Tenax Therapeutics, IncBought (not open market)—
May 11, 2026TENX Tenax Therapeutics, IncBought (not open market)—
May 6, 2026LNSR LENSAR, IncSold (not open market)$7.3K
Mar 19, 2026LNSR LENSAR, IncBought (not open market)—
Feb 18, 2026LNSR LENSAR, IncSold (not open market)$12.2K
Jan 11, 2026LNSR LENSAR, IncSold (not open market)$21.1K

Companies traded

  • TENX Tenax Therapeutics, Inc: 1 buy, last Sep 11, 2026
  • LNSR LENSAR, Inc: 2 buys, last May 6, 2026
  • BCRX Biocryst Pharmaceuticals Inc: 54 sales, last Feb 21, 2020
  • ISPH Inspire Pharmaceuticals Inc: other filings, last May 13, 2011

Get free alerts when Thomas R Staab II files a new trade →